BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 19728331)

  • 1. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
    Lim SC; Choi JE; Kang HS; Han SI
    Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
    Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
    Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro.
    Zhu L; Shan LJ; Liu YJ; Chen D; Xiao XG; Li Y
    J Dig Dis; 2014 Dec; 15(12):684-93. PubMed ID: 25214410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines.
    Liu H; Qin CY; Han GQ; Xu HW; Meng M; Yang Z
    World J Gastroenterol; 2007 Mar; 13(11):1652-8. PubMed ID: 17461466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
    Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC
    J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma.
    Qu K; Xu X; Liu C; Wu Q; Wei J; Meng F; Zhou L; Wang Z; Lei L; Liu P
    Cancer Lett; 2013 Apr; 331(1):105-14. PubMed ID: 23262037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
    Wang Y; Dong L; Li J; Luo M; Shang B
    Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.
    Hong M; Li J; Li S; M Almutairi M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice.
    Liu H; Xu HW; Zhang YZ; Huang Y; Han GQ; Liang TJ; Wei LL; Qin CY; Qin CK
    World J Gastroenterol; 2015 Sep; 21(36):10367-74. PubMed ID: 26420963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells.
    Komori Y; Arisawa S; Takai M; Yokoyama K; Honda M; Hayashi K; Ishigami M; Katano Y; Goto H; Ueyama J; Ishikawa T; Wakusawa S
    Eur J Pharmacol; 2014 Feb; 724():161-7. PubMed ID: 24370495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
    Sharma A; Bhat MK
    Integr Cancer Ther; 2011 Dec; 10(4):NP4-14. PubMed ID: 21994207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
    Liu J; Wei X; Wu Y; Wang Y; Qiu Y; Shi J; Zhou H; Lu Z; Shao M; Yu L; Tong L
    Cell Oncol (Dordr); 2016 Aug; 39(4):333-42. PubMed ID: 27016209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells.
    Du H; Yang W; Chen L; Shi M; Seewoo V; Wang J; Lin A; Liu Z; Qiu W
    Oncol Rep; 2012 Jan; 27(1):143-50. PubMed ID: 21935576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK.
    Yang XH; Zheng X; Cao JG; Xiang HL; Liu F; Lv Y
    World J Gastroenterol; 2010 Jul; 16(27):3385-93. PubMed ID: 20632440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
    Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
    Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells.
    Yuan L; Wei S; Wang J; Liu X
    J Agric Food Chem; 2014 Jun; 62(23):5390-400. PubMed ID: 24841907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells.
    Tian Z; Shen J; Moseman AP; Yang Q; Yang J; Xiao P; Wu E; Kohane IS
    Int J Cancer; 2008 Jan; 122(1):31-8. PubMed ID: 17847033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF; Cao JG; Tian L; Liu F
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
    Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
    Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.